Control of cell proliferation and differentiation in breast and prostate cancer

Funded Activity Summary

Breast and prostate cancer are the most commonly diagnosed cancers in women and men respectively, together accounting for >25% of all newly diagnosed cancers in Australia and other developed countries. Although significant improvements in the management of these cancers have occurred in the past 20 years further research is needed to better understand the molecular mechanisms of disease development and progression. Such research is critical to the better management and ultimate control of these diseases through better treatments and prevention. A multidisciplinary team of cancer researchers at the Garvan Institute of Medical Research, with a 10 year track record of discovery and application of their research into breast and prostate cancer, will employ state-of-the-art research tools to identify new molecules and molecular pathways involved in these diseases. This new information will facilitate the improved management of these cancers through improved assessment of disease progression at the time of diagnosis and the development of new drugs and strategies for treatment and prevention.

Funded Activity Details

Start Date: 01-01-2003

End Date: 01-01-2008

Funding Scheme: Programs

Funding Amount: $5,043,011.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cell Development (Incl. Cell Division And Apoptosis)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Mammary & prostate gland development | Molecular cell biology of breast & prostate cancer | Molecular markers of cancer outcomes | Receptor tyrosine kinases and signal transduction | Sex steroid hormones & cell proliferation/differen

Related Links